What are the requirements for submitting a sequence listing as part of a patent application?
When submitting a sequence listing as part of a patent application, there are specific requirements that must be met: The sequence listing must be submitted as a separate part of the disclosure. It should be presented on its own page or as a separate text file. The sequence listing must comply with the requirements of…
Read MoreWhat are the requirements for submitting a Sequence Listing on read-only optical discs?
When submitting a Sequence Listing on read-only optical discs, the following requirements apply: The specification must contain an incorporation by reference of the material on the read-only optical disc in a separate paragraph. The incorporation by reference must identify the name of the file, the date of creation, and the size of the file in…
Read MoreWhat are the format options for submitting a “Sequence Listing” to the USPTO?
The USPTO provides multiple format options for submitting a “Sequence Listing” as part of a patent application. These options include: As an ASCII plain text file via the USPTO patent electronic filing system On a read-only optical disc As a PDF image file via the USPTO patent electronic filing system On physical sheets of paper…
Read MoreWhat is the recommended format for submitting a “Sequence Listing” in a patent application?
The USPTO recommends submitting a “Sequence Listing” as an ASCII plain text file via the USPTO patent electronic filing system rather than as a PDF image file. This is because: If submitted as an ASCII plain text file in compliance with 37 CFR 1.824, it will serve as both the “Sequence Listing” under 37 CFR…
Read MoreWhat are the requirements for submitting a sequence listing in electronic form via EFS-Web?
Submitting a sequence listing in electronic form via EFS-Web has specific requirements. According to MPEP 2422.03: “A sequence listing submitted in electronic form via EFS-Web to be compliant with the sequence rules must be a text file in ASCII format. The file may be compressed using WinZip or other acceptable compression software. The file name…
Read MoreWhat information is included in patents or patent application publications when a “Sequence Listing” is not printed?
When a “Sequence Listing” is not included in the page images of a patent or patent application publication, a standardized statement appears. This statement includes: An explanation that the patent or application contains a lengthy “Sequence Listing” section. Information on how to access the “Sequence Listing” electronically from the USPTO website. Details on how to…
Read MoreWhat are the requirements for content of a “Sequence Listing” part of the specification under WIPO ST.25?
The requirements for the content of a “Sequence Listing” part of the specification under WIPO ST.25 are outlined in 37 CFR 1.823. However, it’s important to note that these requirements are not applicable to all patent applications. As stated in the MPEP: “[Editor Note: This section is not applicable to applications filed on or after…
Read MoreWhat are the requirements for submitting a “Sequence Listing” in a patent application?
According to MPEP 2427, patent applications containing nucleotide and/or amino acid sequence disclosures must include a “Sequence Listing” as a separate part of the disclosure. This can be submitted in several ways: As an ASCII text file via the USPTO’s electronic filing system On read-only optical discs As a PDF file via EFS-Web or Patent…
Read MoreWhat are the requirements for representing nucleotide and amino acid sequences in a “Sequence Listing”?
According to MPEP 2423.01, the requirements for representing nucleotide and amino acid sequences in a “Sequence Listing” are as follows: The symbols for nucleotide and amino acid characters must be those set forth in Appendices A and C to Subpart G of Part 1 of the CFR. No other symbols shall be used in nucleotide…
Read MoreWhat changes have been made to the “Sequence Listing” requirements for applications filed on or after July 1, 2022?
For patent applications filed on or after July 1, 2022, there have been significant changes to the “Sequence Listing” requirements. The MPEP section 2424.01 includes an important editor’s note: “[Editor Note: This section is not applicable to applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined…
Read More